IBM Retirement Fund’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,899
Closed -$337K 659
2021
Q3
$337K Hold
2,899
0.03% 531
2021
Q2
$643K Sell
2,899
-541
-16% -$105K 0.05% 339
2021
Q1
$455K Sell
3,440
-240
-7% -$38K 0.03% 478
2020
Q4
$637K Buy
3,680
+451
+14% +$61.7K 0.04% 361
2020
Q3
$359K Buy
+3,229
New +$258K 0.03% 469

Other funds holding NVCR

IBM Retirement Fund's NVCR Position: Q4 2021 in Review

IBM Retirement Fund sold out of NovoCure (NVCR) in Q4 2021, closing a stake of 2,899 shares — an estimated $337K sold.

IBM Retirement Fund first reported a position in NVCR in Q3 2020 and held it in 5 quarters. The position peaked at $643K in Q2 2021. 311 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

  • IBM Retirement Fund reported no remaining NovoCure position as of Q4 2021 after selling out during the quarter.
  • IBM Retirement Fund sold 2,899 NovoCure shares in Q4 2021, an estimated $337K.
  • IBM Retirement Fund first reported a position in NovoCure in Q3 2020 and held it in 5 quarters.
  • IBM Retirement Fund's NovoCure position peaked at $643K in Q2 2021.
  • 311 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on IBM Retirement Fund's 13F filing for Q4 2021, filed 19 Jan 2022.